SCHEMBL2156401

SCHEMBL2156401

O=C(O)c1ccc(Cl)c(CC2(Cc3c(Cl)ccc(C(=O)O)c3Cl)COc3ccccc3C2=O)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33
CLCN2 P51788 4/20 0.32
ALDH1A1 P00352 4/20 0.31
MAPT P10636 3/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
GAA P10253 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
PLA2G1B P04054 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
ATG4B Q9Y4P1 1/20 0.31
LMNA P02545 3/20 0.31
HTT P42858 3/20 0.31
NPSR1 Q6W5P4 3/20 0.31
PDK2 Q15119 1/20 0.31
GSK3A P49840 1/20 0.31
GSK3B P49841 1/20 0.31
HPGD P15428 2/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2156506 0.78 FOLH1 (0.41) TSHRCLCN2ALDH1A1MAPTL3MBTL1
SCHEMBL2155728 0.78 LMNA (0.39) TSHRMAPTL3MBTL1LMNAHTT
SCHEMBL2155753 0.76 MEN1 (0.39) ALDH1A1MEN1KMT2AHPGD
SCHEMBL2155984 0.73 AKR1C3 (0.44) ALDH1A1MAPTGAAKDM4EHPGD
SCHEMBL2156976 0.70 APEX1 (0.44) TSHRALDH1A1L3MBTL1GAAKDM4E
SCHEMBL4618449 0.69 KMT2A (0.41) ALDH1A1MAPTL3MBTL1KDM4EMEN1
SCHEMBL4619429 0.66 SMN1; SMN2 (0.41) MAPTKMT2A
SCHEMBL2156979 0.65 PRKCA (0.44) TSHRALDH1A1MAPTGAAKDM4E
SCHEMBL3259535 0.64 NPSR1 (0.40) TSHRALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL2156603 0.64 CYP19A1 (0.43) MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production GRUENENTHAL GMBH (DE) 2008-07-03 US claimed
US-7973072-B2 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example GRUENENTHAL GMBH (DE) 2011-07-05 US disclosed
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production GRUENENTHAL GMBH (DE) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production BCKDK, SYMPK, DHPS TSHR 4824/4885CLCN2 2500/4885ALDH1A1 1598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.